Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.60 by ($0.16), Zacks reports. Novozymes A/S had a return on equity of 6.52% and a net margin of 14.22%.
Novozymes A/S Stock Performance
OTCMKTS NVZMY opened at $69.51 on Thursday. The firm has a market cap of $28.82 billion, a price-to-earnings ratio of 46.97, a PEG ratio of 3.00 and a beta of 0.92. The company has a 50-day simple moving average of $63.48 and a two-hundred day simple moving average of $60.52. The company has a quick ratio of 1.03, a current ratio of 1.67 and a debt-to-equity ratio of 0.27. Novozymes A/S has a 12-month low of $49.90 and a 12-month high of $75.27.
Analysts Set New Price Targets
Several research firms have commented on NVZMY. Zacks Research raised shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a report on Monday, June 8th. Kepler Capital Markets upgraded Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy”.
About Novozymes A/S
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
Featured Stories
- Five stocks we like better than Novozymes A/S
- Analog Devices’ AI Pivot Could Push Shares to Fresh Highs
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
